CARCINOMA IN A POSTMENOPAUSAL ENDOMETRIAL POLYP

Dr K. Ramalingam, Dr D. Arunadevi

Abstract


Introduction:Endometrial polyp is a common pathology found in gynaecological practice.The incidence of
premalignant and malignant findings in endometrial polyps range from 0.5 to 4.8% in the general population and 2 to
10% in postmenopausal women.
case report: A 55yr old P2L2 postmenopausal women came with complaint of vaginal bleeding on and off for 3 months.
On Per vaginal examination uterus retroverted, parous size, fornices free. Ultrasound revealed well defined hypoechoic
lesion of 16.8×14.4 mm in the fundal region of the endometrial cavity Fractional curretage done showed cystic dilatation
of endometrial glands and chronic nonspecific cervicitis. Non descent vaginal hysterectomy + B/L salpingooophorectomy
was done and sent for HPE. Gross examination showed endometrial cavity with a small polyp of 1×0.5cm.
Microscopy showed non secretory cystic dilatation of endometrial glands with no evidence of hyperplasia/malignancy
but the polyp showed features suggestive of a well differentiated endometroid carcinoma villoglandular variant (Grade
1).
Villoglandular carcinoma is characterized by papillary architecture with delicate fibro vascular stalks. Discussion: It is
lined by cuboidal or columnar cells with minimal cellular stratification and mild nuclear pleomorphism . It only invades
the superficial layers of the myometrium, and is usually diagnosed at an early stage. Thus it has a better prognosis than
typical endometrioid carcinoma.
Conclusion: Large symptomatic endometrial polyps, especially those which develop in post menopausal women, have a
tendency to show malignant changes. Careful histological examination of endometrial biopsy to find premalignant and
malignant lesions should be emphasized


Keywords


Polyp,endometrial carcinoma, postmenopausal bleeding

Full Text:

PDF

References


(1) Ali Dastranj Tabrizi, et al .J Res Med Sci. 2011 Apr; 16(4): 574–579.

(2) Rahimi, et al. Int J Gynecol Pathol. 2009;28(6):522–8.

(3) Scott RB. Obstet Gynecol. 1953;1(2):212–8.

(4) Orvieto R, et al. Acta Obstet Gynecol Scand. 1999;78(10):883–6.

(5) Anastasiadis PG, et al. Eur J Gynaecol Oncol. 2000;21(2):180–3.

(6) Goldstein SR ,et al . Am J Obstet Gynecol. 2002;186(4):669–74.

(7) Savelli L, et al. Am J Obstet Gynecol. 2003;188(4):927–31.

(8) Ben- Arie A, et al .Eur J Obstet Gynecol Reprod Biol. 2004 Aug 10;115(2):206-10


Refbacks

  • There are currently no refbacks.